Pfizer, C3651032, PDAC, Physical Activity Monitoring

What is the Purpose of this Study?

Primary: - Estimate the feasibility of deploying a DHT for quantitatively monitoring physical activity in a non-clinical environment Secondary: - Describe DHT-derived physical activity - Estimate the performance of device monitoring processes - Quantify participant comfort and wearability in a non-clinical environment


Eligibility

Not Available


Where can I participate?

CS Cancer at Cedars-Sinai Medical Center : Abrahm Levi


What is the full name of this clinical trial?

A LOW-INTERVENTIONAL STUDY TO ASSESS PHYSICAL ACTIVITY USING DIGITAL HEALTH TECHNOLOGY IN ADULT PARTICIPANTS WITH CACHEXIA AND RECEIVING OR WILL BE RECEIVING FIRST-LINE CHEMOTHERAPY FOR METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA

Study Details
Disease Type/Condition

Pancreas

Principal Investigator

Hendifar, Andrew

Co-Investigators

Arsen Osipov

Age Group

Adult

Phase

N/A

IRB Number

STUDY00004255


How do I learn more about this study?
Name

Abrahm Levi

Email
Abrahm.Levi@cshs.org
Study Detail
Disease Type/Condition

Pancreas

Principal Investigator

Hendifar, Andrew

Age Group

Adult

Phase

N/A

IRB Number

C3651032


Contact
Name

Abrahm Levi

Email
Abrahm.Levi@cshs.org